Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
35.56
+2.24 (6.72%)
At close: Feb 24, 2026, 4:00 PM EST
35.56
0.00 (0.00%)
After-hours: Feb 24, 2026, 4:34 PM EST
Oruka Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$52.70
Upside
+48.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $42 → $45 | Buy | Maintains | $42 → $45 | +26.55% | Jan 13, 2026 |
| BTIG | BTIG | Strong Buy Maintains $63 → $73 | Strong Buy | Maintains | $63 → $73 | +105.29% | Jan 12, 2026 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +40.61% | Jan 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $75 | Buy | Initiates | $75 | +110.91% | Dec 18, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +26.55% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $56 → $63 | Strong Buy | Maintains | $56 → $63 | +77.17% | Nov 13, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +68.73% | Oct 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $40 | Strong Buy | Maintains | $45 → $40 | +12.49% | Oct 27, 2025 |
| Barclays | Barclays | Buy Initiates $48 | Buy | Initiates | $48 | +34.98% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +57.48% | Sep 29, 2025 |
| BTIG | BTIG | Strong Buy Maintains $44 → $56 | Strong Buy | Maintains | $44 → $56 | +57.48% | Sep 17, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +29.36% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +26.55% | Aug 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +26.55% | Jul 23, 2025 |
| Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +12.49% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +26.55% | Feb 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.